PRECHTL; Stefan
Patent Applications and Registrations
Patent applications and USPTO patent grants for PRECHTL; Stefan.The latest application filed is for "thiazole compounds useful as prmt5 inhibitors".
- PRECHTL; Stefan - Berlin DE
| Patent | Date |
|---|---|
| Thiazole Compounds Useful As Prmt5 Inhibitors App 20200123147 - BOUCHE; Lea Aurelie ; et al. | 2020-04-23 |
| Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,604,532 - Hitchcock , et al. | 2020-03-31 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20190284206 - HITCHCOCK; Marion ; et al. | 2019-09-19 |
| Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,266,548 - Hitchcock , et al. | 2019-04-23 |
| Amino-substituted Isothiazoles App 20170334899 - BARFACKER; Lars ; et al. | 2017-11-23 |
| Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20170275267 - HITCHCOCK; Marion ; et al. | 2017-09-28 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20170260198 - HITCHCOCK; Marion ; et al. | 2017-09-14 |
| Amino-substituted Isoxazoles App 20170217946 - BARFACKER; Lars ; et al. | 2017-08-03 |
| Amino-substituted isothiazoles Grant 9,682,995 - Barfacker , et al. June 20, 2 | 2017-06-20 |
| Triazolopyridines Grant 9,676,766 - Schulze , et al. June 13, 2 | 2017-06-13 |
| Substituted benzylpyrazoles Grant 9,643,953 - Hitchcock , et al. May 9, 2 | 2017-05-09 |
| Substituted triazolopyridines Grant 9,555,022 - Schulze , et al. January 31, 2 | 2017-01-31 |
| Imidazopyrazines Grant 9,468,642 - Klar , et al. October 18, 2 | 2016-10-18 |
| Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors Grant 9,340,528 - Bader , et al. May 17, 2 | 2016-05-17 |
| Amino-substituted Isothiazoles App 20150368260 - BARFACKER; Lars ; et al. | 2015-12-24 |
| Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20150141372 - Hitchcock; Marion ; et al. | 2015-05-21 |
| Substituted Benzylpyrazoles App 20140315934 - Hitchcock; Marion ; et al. | 2014-10-23 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20140249133 - Hitchcock; Marion ; et al. | 2014-09-04 |
| Substituted imidazoquinoxalines Grant 8,729,082 - Koppitz , et al. May 20, 2 | 2014-05-20 |
| Substituted triazolopyridines Grant 8,551,980 - Schulze , et al. October 8, 2 | 2013-10-08 |
| Imidazopyrazines App 20130195848 - Klar; Ulrich ; et al. | 2013-08-01 |
| Substituted Triazolopyridines App 20130156756 - Schulze; Volker ; et al. | 2013-06-20 |
| Triazolopyridine Derivatives App 20130121994 - Koppitz; Marcus ; et al. | 2013-05-16 |
| Triazolopyridines App 20120328610 - Schulze; Volker ; et al. | 2012-12-27 |
| Substituted Triazolopyridines App 20120328611 - Schulze; Volker ; et al. | 2012-12-27 |
| Substituted Aminoquinoxalines As Tyrosine Threonine Kinase Inhibitors App 20120263708 - Bader; Benjamin ; et al. | 2012-10-18 |
| Substituted Imidazoquinoxalines App 20120128662 - Koppitz; Marcus ; et al. | 2012-05-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 